Harvest Fund Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72K Sell
149
-562
-79% -$288K ﹤0.01% 323
2025
Q4
$399K Buy
711
+209
+42% +$119K 0.02% 276
2025
Q3
$258K Buy
+502
New +$219K 0.01% 314
2024
Q3
Sell
-1,371
Closed -$564K 692
2024
Q2
$564K Buy
1,371
+1,009
+279% +$400K 0.04% 219
2024
Q1
$146K Buy
+362
New +$127K 0.01% 374
2022
Q1
Sell
-1,142
Closed -$250K 770
2021
Q4
$250K Buy
1,142
+919
+412% +$192K 0.04% 202
2021
Q3
$42K Sell
223
-191
-46% -$34.8K 0.01% 450
2021
Q2
$73K Hold
414
0.01% 342
2021
Q1
$67K Buy
414
+194
+88% +$29.7K 0.01% 337
2020
Q4
$30K Sell
220
-448
-67% -$56.5K ﹤0.01% 445
2020
Q3
$79K Sell
668
-64
-9% -$7.4K 0.01% 313
2020
Q2
$68K Sell
732
-154
-17% -$13.1K 0.01% 287
2020
Q1
$64K Buy
+886
New +$76.9K 0.01% 263
2019
Q4
Sell
-846
Closed -$71K 457
2019
Q3
$71K Buy
+846
New +$63.9K 0.01% 233
2019
Q1
Sell
-537
Closed -$28K 379
2018
Q4
$28K Sell
537
-4,036
-88% -$222K 0.01% 299
2018
Q3
$274K Buy
+4,573
New +$250K 0.05% 109

Other funds holding MEDP

Harvest Fund Management's MEDP Position: Q1 2026 in Review

Harvest Fund Management reduced its Medpace (MEDP) stake by 79% in Q1 2026, selling an estimated $288K and leaving 149 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #323.

Harvest Fund Management first reported a position in MEDP in Q3 2018 and has held it in 16 quarters since. The position peaked at $564K in Q2 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Harvest Fund Management held 149 shares of Medpace worth $72K as of Q1 2026.
  • Harvest Fund Management sold 562 Medpace shares in Q1 2026, an estimated $288K.
  • Medpace made up ﹤0.01% of Harvest Fund Management's portfolio in Q1 2026, its #323 holding.
  • Harvest Fund Management first reported a position in Medpace in Q3 2018 and has held it in 16 quarters since.
  • Harvest Fund Management's Medpace position peaked at $564K in Q2 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.